Mary Woolley

Dear Research Advocate: Congress is on the brink of forcing a government shutdown on Tuesday, October 1. The implications of a shutdown are being subsumed by coverage of the political theater taking place. That is an injustice to Americans, who will be affected. History is illustrative on this point. During the 1995 and 1996 shutdowns , the NIH turned away new patients at the Clinical Center. Research studies housed at federal institutions ceased for the duration of the shutdown; researchers and leaders of industry, academia as well as in government agencies were unable to plan effectively, wasting time and money; the CDC was forced to stop disease surveillance programs, leaving us...
Dear Research Advocate: Congress is on the brink of forcing a government shutdown on Tuesday, October 1. The implications of a shutdown are being subsumed by coverage of the political theater taking place. That is an injustice to Americans, who will be affected. History is illustrative on this point. During the 1995 and 1996 shutdowns , the NIH turned away new patients at the Clinical Center. Research studies housed at federal institutions ceased for the duration of the shutdown; researchers and leaders of industry, academia as well as in government agencies were unable to plan effectively, wasting time and money; the CDC was forced to stop disease surveillance programs, leaving us...
Advocacy Academy participants: Mesias Pedroza, PhD, Baylor College of Medicine; Chloe N. Poston, PhD, Eli Lilly and Company; Jeffery G. Mellott, PhD Northeast Ohio Medical University Last week, we held our inaugural Advocacy Academy, bringing 12 postdoctoral researchers from across the U.S. to Washington, D.C. A two-day advocacy training program that culminated in Congressional visits with the participants’€™ representatives. We selected this group of motivated and concerned early-career scientists from a diversity of institutions, including Northeast Ohio Medical University, UCSF, Memorial Sloan-Kettering Cancer Center, Baylor College of Medicine, the University of Pennsylvania School of...
Dear Research Advocate: With only eleven days until the end of the fiscal year, Congress has yet to pass a continuing resolution (CR) to fund the government past September 30. The House is expected to vote on, and pass, a bill that does not include funding to administer Obamacare as part of their “CR;” the Senate and the President will not agree, thus almost certainly forcing a government shutdown. The issue of what to do about sequestration is almost certainly not going to be resolved as part of negotiating this short-term CR. That means we must continue to fight for action, and there has been a flurry of advocacy on Capitol Hill. This included, but was certainly not limited to the...
Advocacy Academy participants: Mesias Pedroza, PhD, Baylor College of Medicine; Chloe N. Poston, PhD, Eli Lilly and Company; Jeffery G. Mellott, PhD Northeast Ohio Medical University Last week, we held our inaugural Advocacy Academy, bringing 12 postdoctoral researchers from across the U.S. to Washington, D.C. A two-day advocacy training program that culminated in Congressional visits with the participants’€™ representatives. We selected this group of motivated and concerned early-career scientists from a diversity of institutions, including Northeast Ohio Medical University, UCSF, Memorial Sloan-Kettering Cancer Center, Baylor College of Medicine, the University of Pennsylvania School of...
Dear Research Advocate: With only eleven days until the end of the fiscal year, Congress has yet to pass a continuing resolution (CR) to fund the government past September 30. The House is expected to vote on, and pass, a bill that does not include funding to administer Obamacare as part of their “CR;” the Senate and the President will not agree, thus almost certainly forcing a government shutdown. The issue of what to do about sequestration is almost certainly not going to be resolved as part of negotiating this short-term CR. That means we must continue to fight for action, and there has been a flurry of advocacy on Capitol Hill. This included, but was certainly not limited to the...
Research!America’€™s National Health Research Forum ’€” held September 12 at the Newseum’€™s Knight Conference Center in Washington, DC ’€” examined the current and future state of research to improve health. This year’€™s theme was ’€œStraight Talk about the Future of Medical and Health Research.’€ Three expert panels delved into different aspects of the research ecosystem. Research!America’€™s president and CEO, Mary Woolley, and chair, The Honorable John Edward Porter, opened the program. Porter introduced Bart Peterson, JD, senior vice president of corporate affairs and communications at Lilly who delivered a brief keynote speech. ’€œWe developed an innovation ecosystem, and that...
Research!America’€™s National Health Research Forum ’€” held September 12 at the Newseum’€™s Knight Conference Center in Washington, DC ’€” examined the current and future state of research to improve health. This year’€™s theme was ’€œStraight Talk about the Future of Medical and Health Research.’€ Three expert panels delved into different aspects of the research ecosystem. Research!America’€™s president and CEO, Mary Woolley, and chair, The Honorable John Edward Porter, opened the program. Porter introduced Bart Peterson, JD, senior vice president of corporate affairs and communications at Lilly who delivered a brief keynote speech. ’€œWe developed an innovation ecosystem, and that...
Clinical research is key to saving lives, lowering health care costs and reducing waste and inefficiencies in our health care system. To highlight the latest insights from prominent health and research leaders, The Association of Clinical Research Organization has launched a new video series about the importance of clinical research. In the latest installment, John Lewis, Vice President of Public Affairs interviews Research!America president and CEO, Mary Woolley about what’€™s next for research, the public perception of clinical trials and how we should encourage more minority participation in clinical trials. According to a recent Research!America poll , altruism is a strong motivating...
Dear Research Advocate: I am sending out my letter early this week so that you can plan now, if you are not able to be with us in person tomorrow in Washington, to join us electronically for our National Health Research Forum. With the theme of ’€œStraight Talk,’€ our first-rate panelists will speak candidly about where our medical and health ecosystem is headed today ’€” what the possibilities are, if we give research and innovation every chance to succeed ’€” and what the policy and funding challenges are as we go forward. We thank Lilly, our lead sponsor; all our additional sponsors; and WebMD for live-streaming the event on their website at www.webmd.com/researchforum . On the funding...

Pages

Sidebar Quote

Public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.
Abraham Lincoln